The market opportunities lie in providing training for drug safety monitoring, focusing on clinical safety and post-marketing safety. This includes teaching international standards, best practices, ...

The main market opportunities include leveraging AI for enhanced drug safety, improving adverse event reporting, optimizing signal detection, and advancing risk management in pharmacovigilance, ...

The evaluation of drug safety in clinical trials is a critical element of the drug development process, ensuring that therapeutic benefits outweigh potential harms. Clinical trials, particularly in ...

This series is designed for all students, staff, and faculty who conduct interventional studies, observational studies, or behavioral and public health research. Whether you're new to clinical ...

Efficacy and safety of surufatinib in unresectable or metastatic grade 3 pancreatic neuroendocrine tumors (NET G3): Real-world analysis. Phase II study of mFOLFIRINOX efficacy as first and subsequent ...

In the article that accompanies this editorial, Sun et al 9 used large language models (LLMs) to detect immune-related adverse events (irAEs) from electronic health records and demonstrated that LLMs ...

WASHINGTON - The Food and Drug Administration has launched what it is describing as a "unified dashboard" for identifying and monitoring unexpected side effects or injuries caused by approved medical ...